Immediate Suture or Directed Wound Healing? Comparative Study of Their Respective Values Following a Punch Skin Biopsy (CICAT)
NCT ID: NCT04623372
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
400 participants
INTERVENTIONAL
2021-02-03
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence and Complications of Suture in the ED
NCT05289232
Comparison of Suturing and Packing of Drained Abscesses
NCT00465049
Management and Short Term Outcome of Traumatic Wounds in the Emergency Department
NCT05510362
A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites
NCT01722994
Intracutaneous Versus Transcutaneous Sutures in the Face (IC vs TC Sutures)
NCT02125058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The protocol will consist in a monocentric, prospective, randomized and controlled, interventional study. It will be carried out with two parallel groups, in a non-inferiority setting. All the included participants will undergo a skin biopsy using a punch of 4 mm diameter. Then they will either get a suture by separated knots using a non-absorbable 4.0 wire and a dry dressing, either get only a dry dressing. All the subjects will receive a phone call at five days after the skin biopsy in order to collect the self-evaluation of the maximal experienced pain during the healing period. They will also have a single follow-up appointment one month after the inclusion and a photograph of the scar will be taken during this medical consultation. This picture will be evaluated by a blind independent investigator without the presence of the patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
suture
suture
suture by separated knots using a non-absorbable 4.0 wire and application of a dry dressing after the punch skin-biopsy
Directed wound healing
directed wound healing
application of a dry dressing without any prior suture after the skin biopsy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
suture
suture by separated knots using a non-absorbable 4.0 wire and application of a dry dressing after the punch skin-biopsy
directed wound healing
application of a dry dressing without any prior suture after the skin biopsy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* either hospitalized patient in a conventional or in a day care department, either seen at a medical appointment in Le Mans General Hospital
* person on whom the indication of one or several skin biopsy(ies) using a punch of 4 mm diameter has been established
* affiliated or beneficiary of a statutory social insurance scheme
* free and informed written consent, signed by both the participant and the investigator (the day of inclusion at the latest and prior to any examination needed by the protocol) after an oral and written information
Exclusion Criteria
* pregnant, breastfeeding or parturient woman
* person deprived of liberty by an administrative act or a court decision
* patient requiring compulsory mental health care
* minor or legally protected adult
* patient that is no longer in a condition to express his or her wishes
* person that have participated or that are taking part in an interventional study over the past 30 days (condition of exclusivity)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier le Mans
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Du Mans
Le Mans, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHM-2020/S11/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.